Rheumatologists, take heart! We may be doing something right

por van Vollenhoven, Ronald F
Publicado 2008

Sex differences in rheumatoid arthritis: more than meets the eye...

por van Vollenhoven, Ronald F
Publicado 2009

Advances in the treatment of rheumatoid arthritis

por Vivar, Nancy, Van Vollenhoven, Ronald F.
Publicado 2014

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?

por Nagy, György, van Vollenhoven, Ronald F
Publicado 2015

Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatolo...

por van Vollenhoven, Ronald F, Tas, Sander W, Nurmohamed, Michael T
Publicado 2023

Patient Preference Assessment Reveals Disease Aspects Not Covered by Recommended Outcomes in Polymyositis and Dermatomyositis

por Alemo Munters, Li, van Vollenhoven, Ronald F., Alexanderson, Helene
Publicado 2011

Early start and stop of biologics: has the time come?

por van Vollenhoven, Ronald F, Nagy, György, Tak, Paul P
Publicado 2014

Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study

por Lesuis, Nienke, Befrits, Ragnar, Nyberg, Filippa, van Vollenhoven, Ronald F
Publicado 2012

Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine

por Lems, Willem, Boers, Maarten, van Vollenhoven, Ronald F, Nurmohamed, Mike
Publicado 2021

Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious

por van Vollenhoven, Ronald F, Ernestam, Sofia, Harju, Anders, Bratt, Johan, Klareskog, Lars
Publicado 2003

Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial

por Levitsky, Adrian, Erlandsson, Malin C., van Vollenhoven, Ronald F., Bokarewa, Maria I.
Publicado 2015

A neutrophil signature is strongly associated with increased cardiovascular risk in gout

por Vedder, Daisy, Gerritsen, Martijn, Nurmohamed, Michael T, van Vollenhoven, Ronald F, Lood, Christian
Publicado 2020

Long-Term Dietary Changes after Diagnosis of Rheumatoid Arthritis in Swedish Women: Data from a Population-Based Cohort

por Lourdudoss, Cecilia, Arnaud, Laurent, Wolk, Alicja, van Vollenhoven, Ronald F., Di Giuseppe, Daniela
Publicado 2018

Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls

por Bultink, Irene E M, de Vries, Frank, van Vollenhoven, Ronald F, Lalmohamed, Arief
Publicado 2020

Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort

por Györi, Noémi, Giannakou, Ioanna, Chatzidionysiou, Katerina, Magder, Laurence, van Vollenhoven, Ronald F, Petri, Michelle
Publicado 2017

Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial

por Rezaei, Hamed, Saevarsdottir, Saedis, Geborek, Pierre, Petersson, Ingemar F, van Vollenhoven, Ronald F, Forslind, Kristina
Publicado 2013

Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid...

por Smolen, Josef S, van Vollenhoven, Ronald F, Florentinus, Stefan, Chen, Su, Suboticki, Jessica L, Kavanaugh, Arthur
Publicado 2018

Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials

por Bruce, Ian N, van Vollenhoven, Ronald F, Psachoulia, Konstantina, Lindholm, Catharina, Maho, Emmanuelle, Tummala, Raj
Publicado 2023

Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial

por Levitsky, Adrian, Brismar, Kerstin, Hafström, Ingiäld, Hambardzumyan, Karen, Lourdudoss, Cecilia, van Vollenhoven, Ronald F, Saevarsdottir, Saedis
Publicado 2017

Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studi...

por Fleischmann, Roy, Wollenhaupt, Jürgen, Takiya, Liza, Maniccia, Anna, Kwok, Kenneth, Wang, Lisy, van Vollenhoven, Ronald F
Publicado 2017